ALX Oncology Holdings Inc. (ALXO) Tops Q4 EPS by 12c

ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q4 EPS of ($0.55), $0.12 better than the analyst estimate of ($0.67).

For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.

You May Also Be Interested In

• ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
• NexPoint Residential Trust (NXRT) Reiterated at Market Perform by Citizens Post Guidance Cut
• Jaguar Health (JAGX) Tops Q2 EPS by 3647c